142.65
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LRCX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$139.59
Aprire:
$139.8
Volume 24 ore:
14.64M
Relative Volume:
1.30
Capitalizzazione di mercato:
$179.17B
Reddito:
$19.59B
Utile/perdita netta:
$5.81B
Rapporto P/E:
31.43
EPS:
4.538
Flusso di cassa netto:
$5.55B
1 W Prestazione:
-3.78%
1M Prestazione:
-1.65%
6M Prestazione:
+72.30%
1 anno Prestazione:
+95.06%
Lam Research Corp Stock (LRCX) Company Profile
Nome
Lam Research Corp
Settore
Industria
Telefono
(510) 659-0200
Indirizzo
4650 CUSHING BLVD, FREMONT, CA
Confronta LRCX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LRCX
Lam Research Corp
|
142.65 | 175.33B | 19.59B | 5.81B | 5.55B | 4.538 |
|
ASML
Asml Holding Nv
|
966.57 | 380.79B | 35.54B | 10.43B | 9.71B | 26.71 |
|
AMAT
Applied Materials Inc
|
224.00 | 175.44B | 28.37B | 7.00B | 5.70B | 8.6769 |
|
KLAC
Kla Corp
|
1,097.12 | 144.85B | 12.52B | 4.24B | 3.87B | 31.85 |
|
TER
Teradyne Inc
|
158.91 | 24.42B | 2.83B | 469.17M | 568.90M | 2.8828 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-23 | Reiterato | TD Cowen | Buy |
| 2025-09-30 | Iniziato | HSBC Securities | Hold |
| 2025-09-29 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Ripresa | Erste Group | Buy |
| 2025-07-31 | Downgrade | Summit Insights | Buy → Hold |
| 2025-07-31 | Reiterato | TD Cowen | Buy |
| 2025-07-10 | Iniziato | Goldman | Buy |
| 2025-04-24 | Reiterato | TD Cowen | Buy |
| 2025-03-20 | Ripresa | Oppenheimer | Outperform |
| 2025-02-20 | Aggiornamento | Susquehanna | Neutral → Positive |
| 2025-01-30 | Aggiornamento | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Iniziato | Cleveland Research | Neutral |
| 2024-08-01 | Reiterato | TD Cowen | Buy |
| 2024-05-13 | Iniziato | Jefferies | Buy |
| 2024-04-25 | Reiterato | TD Cowen | Buy |
| 2024-04-19 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Reiterato | Needham | Buy |
| 2024-04-16 | Iniziato | Evercore ISI | Outperform |
| 2024-04-11 | Ripresa | Deutsche Bank | Hold |
| 2024-01-25 | Reiterato | TD Cowen | Outperform |
| 2024-01-23 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Downgrade | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Iniziato | Redburn Atlantic | Buy |
| 2023-10-17 | Iniziato | Raymond James | Outperform |
| 2023-10-13 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-15 | Iniziato | Wolfe Research | Outperform |
| 2023-07-24 | Reiterato | Mizuho | Buy |
| 2023-07-24 | Aggiornamento | Stifel | Hold → Buy |
| 2023-04-20 | Reiterato | Berenberg | Buy |
| 2023-04-20 | Reiterato | Evercore ISI | Outperform |
| 2023-04-20 | Reiterato | JP Morgan | Overweight |
| 2023-04-20 | Reiterato | Jefferies | Buy |
| 2023-04-20 | Reiterato | Mizuho | Buy |
| 2023-04-20 | Reiterato | Stifel | Hold |
| 2023-04-20 | Reiterato | Wells Fargo | Equal Weight |
| 2023-03-13 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Ripresa | Stifel | Hold |
| 2022-12-12 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Reiterato | B. Riley Securities | Neutral |
| 2022-10-20 | Reiterato | BofA Securities | Buy |
| 2022-10-20 | Reiterato | DA Davidson | Neutral |
| 2022-10-20 | Reiterato | Evercore ISI | Outperform |
| 2022-10-20 | Reiterato | JP Morgan | Overweight |
| 2022-10-20 | Reiterato | Jefferies | Buy |
| 2022-10-20 | Aggiornamento | Summit Insights | Hold → Buy |
| 2022-10-20 | Reiterato | Wells Fargo | Equal Weight |
| 2022-07-25 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Reiterato | Barclays | Overweight |
| 2022-01-27 | Reiterato | Deutsche Bank | Hold |
| 2022-01-27 | Reiterato | Evercore ISI | Outperform |
| 2022-01-27 | Reiterato | Stifel | Buy |
| 2022-01-27 | Reiterato | Susquehanna | Neutral |
| 2022-01-27 | Reiterato | UBS | Buy |
| 2022-01-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Reiterato | Barclays | Overweight |
| 2022-01-10 | Reiterato | BofA Securities | Buy |
| 2022-01-05 | Ripresa | Jefferies | Buy |
| 2021-12-15 | Reiterato | Deutsche Bank | Hold |
| 2021-10-21 | Reiterato | B. Riley Securities | Buy |
| 2021-10-21 | Downgrade | Summit Insights | Buy → Hold |
| 2021-10-15 | Iniziato | Piper Sandler | Neutral |
| 2021-09-14 | Downgrade | Susquehanna | Positive → Neutral |
| 2021-09-07 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Reiterato | Mizuho | Buy |
| 2021-07-29 | Reiterato | Stifel | Buy |
| 2021-07-29 | Reiterato | UBS | Buy |
| 2021-07-29 | Reiterato | Wells Fargo | Equal Weight |
| 2021-03-31 | Iniziato | Bernstein | Outperform |
| 2021-01-28 | Reiterato | Cowen | Outperform |
| 2021-01-08 | Downgrade | Needham | Buy → Hold |
| 2020-12-17 | Downgrade | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Reiterato | Goldman | Buy |
| 2020-10-22 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Reiterato | Mizuho | Buy |
| 2020-10-22 | Reiterato | Morgan Stanley | Overweight |
| 2020-10-22 | Reiterato | RBC Capital Mkts | Outperform |
| 2020-10-22 | Reiterato | Stifel | Buy |
| 2020-10-22 | Reiterato | UBS | Buy |
| 2020-09-21 | Aggiornamento | Stifel | Hold → Buy |
| 2020-07-30 | Reiterato | Cowen | Outperform |
| 2020-07-21 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Downgrade | Stifel | Buy → Hold |
| 2020-06-16 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Iniziato | Barclays | Overweight |
| 2020-04-23 | Reiterato | Needham | Buy |
| 2020-04-08 | Iniziato | Exane BNP Paribas | Outperform |
| 2020-04-03 | Aggiornamento | Nomura | Neutral → Buy |
| 2020-04-02 | Downgrade | DA Davidson | Buy → Neutral |
| 2020-03-27 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Aggiornamento | UBS | Sell → Buy |
Mostra tutto
Lam Research Corp Borsa (LRCX) Ultime notizie
What Are Wall Street Analysts’ Target Price for Lam Research Corporation Stock? - MSN
Stevens Capital Management LP Purchases New Stake in Lam Research Corporation $LRCX - MarketBeat
Richard W. Paul & Associates LLC Buys 1,779 Shares of Lam Research Corporation $LRCX - MarketBeat
Rhumbline Advisers Trims Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Evelyn Partners Investment Management Services Ltd Buys 37,668 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stake Increased by Franklin Resources Inc. - MarketBeat
Lam Research Corporation $LRCX Stock Position Reduced by Personal CFO Solutions LLC - MarketBeat
Lam Research opens $65 million office building in Oregon By Investing.com - Investing.com Nigeria
/C O R R E C T I O N -- Lam Research Corporation/ - Yahoo Finance
Lam Research (NASDAQ:LRCX) Trading 2.2% HigherShould You Buy? - MarketBeat
Lam Research Opens 120,000 SQFT Office Facility in Tualatin in to Accelerate Semiconductor Industry Leadership in AI Era - The Registry Pacific Northwest Real Estate
Lam Research opens $65M office in Oregon in response to expanding semiconductor demand - MSN
Lam Research unveils new Oregon facility as chipmaker rebounds from downturn - The Business Journals
Lam Research opens $65 million office building in Tualatin, Oregon - StreetInsider
Lam Research opens $65M building in Tualatin, with more growth in the works - The Business Journals
Lam Research Corporation $LRCX Holdings Raised by Swiss National Bank - MarketBeat
JPMorgan Chase & Co. Purchases 5,102,589 Shares of Lam Research Corporation $LRCX - MarketBeat
DNB Asset Management AS Buys 566,754 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research (NASDAQ:LRCX) Trading Down 6.2%Here's What Happened - MarketBeat
Applied Materials: Up 40% in 2025 With Room to Run Long-Term - Investing.com
The Zacks Analyst Blog Highlights Walmart, Intuitive Surgical, Lam Research and BV Financial - Yahoo Finance
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Top Stock Reports for Walmart, Intuitive Surgical & Lam Research - Yahoo Finance
Lam Research Corporation stock volume spike explainedWeekly Trade Analysis & Consistent Growth Stock Picks - newser.com
Frank Rimerman Advisors LLC Sells 18,181 Shares of Lam Research Corporation $LRCX - MarketBeat
Lam Research Corp. Opens with a 5.12% Gain Amid Market Decline - Markets Mojo
ARS Investment Partners LLC Acquires 4,504 Shares of Lam Research Corporation $LRCX - MarketBeat
NAA LARGE CAP VALUE FUND's Lam Research Corp(LRCX) Holding History - GuruFocus
Lam Research Corporation Announces Participation at Upcoming Conference - Finviz
Lam Research (NASDAQ:LRCX) Shares Down 2.9% After Insider Selling - MarketBeat
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research (NASDAQ: LRCX) to join UBS Global Technology and AI Conference on Dec. 2 - Stock Titan
Vanguard Group Inc. Has $12.71 Billion Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Purus Wealth Management LLC Acquires Shares of 2,740 Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Nomura Asset Management Co. Ltd. - MarketBeat
Rockefeller Capital Management L.P. Has $27.34 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Black Creek Investment Management Inc. Increases Stock Position in Lam Research Corporation $LRCX - MarketBeat
One Giant Leap for AI Physics: NVIDIA Apollo Unveiled as Open Model Family for Scientific Simulation - NVIDIA Blog
Lam Research (NASDAQ:LRCX) CFO Sells $6,036,048.00 in Stock - MarketBeat
LAM Research CFO Sells Over $6 Million in Company Stock - TradingView
CFO Bettinger Sells 40,080 ($6M) Of Lam Research Corp [LRCX] - TradingView
[Form 4] LAM RESEARCH CORP Insider Trading Activity - Stock Titan
Lam Research Corporation $LRCX Shares Purchased by Westpac Banking Corp - MarketBeat
Thoroughbred Financial Services LLC Has $1 Million Stake in Lam Research Corporation $LRCX - MarketBeat
Intrust Bank NA Decreases Stock Holdings in Lam Research Corporation $LRCX - MarketBeat
Lam Research Corporation $LRCX Stock Holdings Increased by Raiffeisen Bank International AG - MarketBeat
Cornerstone Advisors LLC Sells 36,000 Shares of Lam Research Corporation $LRCX - MarketBeat
How Lam Research Corporation stock benefits from strong dollarJuly 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Is Lam Research Corporation stock bottoming outQuarterly Portfolio Summary & High Accuracy Buy Signal Tips - newser.com
Lam Research's (LRCX) Going to "Have Orders as Far as the Eye Can See," Says Jim Cramer - Finviz
Lam Research’s (LRCX) Going to “Have Orders as Far as the Eye Can See,” Says Jim Cramer - Insider Monkey
Lam Research Corp Azioni (LRCX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):